References
- Dumas A, Luis IV, Bovagnet T, et al. Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO). J Clin Oncol. 2019;38(7):734–743.
- Iacoviello L, Bonaccio M, de Gaetano G, et al. Epidemiology of breast cancer, a paradigm of the "common soil" hypothesis. Semin Cancer Biol. 2020;S1044–579X(20)30043–2.
- Afifi AM, Saad AM, Al-Husseini MJ, et al. Causes of death after breast cancer diagnosis: a US population-based analysis. Cancer. 2020;126(7):1559–1567.
- Zavala VA, Serrano-Gomez SJ, Dutil J, et al. Genetic epidemiology of breast cancer in Latin America. Genes. 2019;10(2):153.
- Merino Bonilla JA, Torres Tabanera M, Ros Mendoza LH. Breast cancer in the 21st century: from early detection to new therapies. Radiologia. 2017;59(5):368–379.
- L H, Y S, W R, et al. ARHGEF10 gene polymorphism is closely associated with the risk of ischemic stroke in Northern Han Chinese population. Neurol Res. 2017;39:158–164.
- Zamponi GW, Striessnig J, Koschak A, et al. The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67(4):821–870.
- Cottrell GS, Soubrane CH, Hounshell JA, et al. CACHD1 is an α2δ-like protein that modulates CaV3 voltage-gated calcium channel activity. J Neurosci. 2018;38(43):9186–9201.
- Phan NN, Wang CY, Chen CF, et al. Voltage-gated calcium channels: novel targets for cancer therapy. Oncol Lett. 2017;14(2):2059–2074.
- Wang CY, Lai MD, Phan NN, et al. Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients. PLoS One. 2015;10(7):e0125766
- Kwasnik A, von Kriegsheim A, Irving A, et al. Potential mechanisms of calcium dependent regulation of the mammalian cell cycle revealed by comprehensive unbiased label-free nLC-MS/MS quantitative proteomics. J Proteomics. 2018; 170:151–166.
- Barrack DS, Thul R, Owen MR. Modelling cell cycle synchronisation in networks of coupled radial glial cells. J Theor Biol. 2015;377:85–97.
- Tiwari M, Prasad S, Shrivastav TG, et al. Calcium signaling during meiotic cell cycle regulation and apoptosis in mammalian oocytes. J Cell Physiol. 2017;232(5):976–981.
- Bong AHL, Monteith GR. Calcium signaling and the therapeutic targeting of cancer cells. Biochimica et biophysica acta. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt B):1786–1794.
- Bunda A, LaCarubba B, Bertolino M, et al. Cacna1b alternative splicing impacts excitatory neurotransmission and is linked to behavioral responses to aversive stimuli. Mol Brain. 2019;12(1):81–81.
- Lee MS. Recent progress in the discovery and development of N-type calcium channel modulators for the treatment of pain. Prog Med Chem. 2014;53:147–186.
- Parmar MB, Arteaga Ballesteros BE, Fu T, et al. Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells. J Biomed Mater Res A. 2016;104(12):3031–3044.
- Hosooka T, Ogawa W. A novel role for the cell cycle regulatory complex cyclin D1-CDK4 in gluconeogenesis. J Diabetes Investig. 2016;7(1):27–28.
- Villegas SL, Darb-Esfahani S, von Minckwitz G, et al. Expression of cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer. Breast Cancer Res Treat. 2018;168(1):179–187.
- Wu K, Zhang H, Fu Y, et al. TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells. Mol Med Report. 2018;18:3411–3420.
- Prasad CP, Manchanda M, Mohapatra P, et al. WNT5A as a therapeutic target in breast cancer. Cancer Metastasis Rev. 2018;37(4):767–778.
- Huang J, Li H, Ren G. Epithelial-mesenchymal transition and drug resistance in breast cancer (Review). Int J Oncol. 2015;47(3):840–848.
- Zhang Q, Zhu B, Qian J, et al. miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B. Onco Targets Ther. 2019;12:8367–8378.
- Zhou P, Wang C, Hu Z, et al. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway. BMC Cancer. 2017;17(1):813.
- Seton-Rogers S. Epithelial-mesenchymal transition: Untangling EMT's functions. Nat Rev Cancer. 2016;16(1):1.
- Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7(6):415–428.
- Xu M, Zhang Y, Cui M, et al. Mortalin contributes to colorectal cancer by promoting proliferation and epithelial-mesenchymal transition. IUBMB Life. 2020;72(4):771–781.
- Zhang L, Xu L, Zhang F, et al. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle (Georgetown, Tex.). 2017;16(8):737–745.
- Bajrami I, Marlow R, van de Ven M, et al. E-Cadherin/ROS1 inhibitor synthetic lethality in breast cancer. Cancer Discov. 2018;8(4):498–515.
- Ma A, Chowdhury EH. Cadherins: the superfamily critically involved in breast cancer. Curr Pharm Des. 2016;22:616–638.
- Jin Y, Zhang Y, Li B, et al. TRIM21 mediates ubiquitination of Snail and modulates epithelial to mesenchymal transition in breast cancer cells. Int J Biol Macromol. 2019;124:846–853.